AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $565,361 | +58.8% | 24,613 | +257.0% | 0.02% | -51.5% |
| Q1 2021 | $356,000 | -12.5% | 6,894 | -40.7% | 0.03% | +26.9% |
| Q3 2020 | $407,000 | -21.9% | 11,622 | +19.4% | 0.03% | -27.8% |
| Q2 2020 | $521,000 | -22.6% | 9,737 | -48.6% | 0.04% | -26.5% |
| Q1 2020 | $673,000 | -36.1% | 18,960 | -10.3% | 0.05% | -48.4% |
| Q2 2019 | $1,054,000 | +30.0% | 21,138 | +20.2% | 0.10% | +86.3% |
| Q4 2018 | $811,000 | +284.4% | 17,584 | +376.5% | 0.05% | +121.7% |
| Q4 2017 | $211,000 | – | 3,690 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |